Rocket Pharmaceuticals Inc logo

Rocket Pharmaceuticals Inc

$ 17.22 +1.72 (+11.1%) 10:08 PM EST
P/E:
At Loss
P/B:
2.91
Market Cap:
$ 1.14B
Enterprise V:
$ 724.67M
Volume:
3.78M
Avg Vol (2M):
968.80K
Also Trade In:
Volume:
3.78M
Market Cap $:
1.14B
PE Ratio:
At Loss
Avg Vol (2-Month):
968.80K
Enterprise Value $:
724.67M
PB Ratio:
2.91
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
Name Current Vs Industry Vs History
Cash-To-Debt 14.43
Equity-to-Asset 0.9
Debt-to-Equity 0.06
Debt-to-EBITDA -0.12
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 79.81
9-Day RSI 68.94
14-Day RSI 62.06
6-1 Month Momentum % -6.61
12-1 Month Momentum % -46.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.41
Quick Ratio 13.41
Cash Ratio 13.23

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.6

Financials (Next Earnings Date:2022-11-04 Est.)

RCKT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RCKT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.98
Beta 1.2
Volatility % 55.32
14-Day RSI 62.06
14-Day ATR ($) 1.192552
20-Day SMA ($) 14.5085
12-1 Month Momentum % -46.41
52-Week Range ($) 7.565 - 36.87
Shares Outstanding (Mil) 66.05

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rocket Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Rocket Pharmaceuticals Inc Analysis

Share your research

Headlines

See More
No news.